Clinical outcomes of extensive-stage small cell lung cancer patients treated with thoracic radiotherapy at different times and fractionations
Abstract Objective The purpose of this study was to assess whether thoracic radiotherapy (TRT) combined with chemotherapy (CHT) showed promising anti-tumour activity in extensive-stage small cell lung cancer (ES-SCLC), to explore practice patterns for the radiation time and dose/fractionation and to...
Main Authors: | Jinmin Han, Chengrui Fu, Baosheng Li |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-03-01
|
Series: | Radiation Oncology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13014-021-01773-x |
Similar Items
-
Long Term Results of Single-Fraction Carbon-Ion Radiotherapy for Non-Small Cell Lung Cancer
by: Takashi Ono, et al.
Published: (2021-12-01) -
The Risk Factors for Radiation Pneumonitis after Single-Fraction Carbon-Ion Radiotherapy for Lung Cancer or Metastasis
by: Takashi Ono, et al.
Published: (2021-06-01) -
Overlap time is an independent risk factor of radiation pneumonitis for patients treated with simultaneous EGFR-TKI and thoracic radiotherapy
by: Wenxiao Jia, et al.
Published: (2021-02-01) -
Benefit from thoracic radiotherapy in patients with extensive-disease small-cell lung cancer with elevated lactate dehydrogenase
by: Qin T, et al.
Published: (2016-03-01) -
Real-World Analysis of the Impact of Radiotherapy on Immunotherapy Efficacy in Non-Small Cell Lung Cancer
by: Amir Onn, et al.
Published: (2021-06-01)